Company Presentation • 12 Feb 2026 21:30
Q4 2025
Company Presentation • 10 Nov 2025 21:30
Q3 2025
Company Presentation • 05 Aug 2025 20:30
Q2 2025
Company Presentation • 01 May 2025 20:30
Q1 2025
Company Presentation • 13 Feb 2025 21:30
𝛼SK or SearchENTITY
Organon & (OGN US)
Organon & (OGN US)
10
Analysis
Health Care • United States
Organon & Co. operates as a pharmaceutical company. The Company develops and produces medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies, and asthma. Organon & Co serves customers worldwide.
morex